1,310
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Testicular-cancer survivors experience compromised language following chemotherapy: Findings in a Swedish population-based study 3–26 years after treatment

, , , , , , , & show all
Pages 185-197 | Received 11 Nov 2010, Accepted 27 Jun 2011, Published online: 18 Aug 2011

References

  • Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Stahl O, Klepp O, . Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: A report from the Swedish-Norwegian Testicular Cancer Group. J Clin Oncol Epub 2011 Apr 11.
  • Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Medical treatment of advanced testicular cancer. JAMA 2008;299: 672–84.
  • Heflin LH, Meyerowitz BE, Hall P, Lichtenstein P, Johansson B, Pedersen NL, . Cancer as a risk factor for long-term cognitive deficits and dementia. J Natl Cancer Inst 2005;97:854–6.
  • van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, . Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210–8.
  • Castellon S, Ganz PA. Neuropsychological studies in breast cancer: In search of chemobrain. Breast Cancer Res Treat 2009;116:125–7.
  • Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. J Clin Oncol 2004;22:2233–9.
  • Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research. J Clin Oncol 2007;25:2455–63.
  • Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 2007;63:183–202.
  • Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999;340: 1383–9.
  • Kreicbergs U, Valdimarsdottir U, Onelov E, Henter JI, Steineck G. Talking about death with children who have severe malignant disease. N Engl J Med 2004;351:1175–86.
  • Steineck G, Bergmark K, Henningsohn L, al-Abany M, Dickman PW, Helgason A. Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol 2002;41:244–52.
  • Steineck G, Hunt H, Adolfsson J. A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncol 2006;45:421–9.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.
  • Skoogh J, Steineck G, Cavallin-Stahl E, Wilderang U, Hakansson UK, Johansson B, . Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: A population-based long-term follow-up of testicular cancer survivors. Int J Androl 2011;34:183–92.
  • Skoogh J, Ylitalo N, Larsson Omerov P, Hauksdottir A, Nyberg U, Wilderang U, . ‘A no means no’–measuring depression using a single-item question versus Hospital Anxiety and Depression Scale (HADS-D). Ann Oncol 2010; 21:1905–9.
  • Fossa SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, . Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 2003;21:1107–18.
  • Pedersen AD, Rossen P, Mehlsen MY, Pedersen CG, Zachariae R, von der Maase H. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc 2009;15:296–301.
  • Schagen SB, Boogerd W, Muller MJ, Huinink WT, Moonen L, Meinhardt W, . Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 2008;47:63–70.
  • Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, . The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
  • Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: Evaluation with patient interview after formal assessment. Psychooncology 2006;15:921–30.
  • Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006;20:76–89.
  • Valenzuela MJ, Sachdev P. Brain reserve and cognitive decline: A non-parametric systematic review. Psychol Med 2006;36:1065–73.
  • White L, Katzman R, Losonczy K, Salive M, Wallace R, Berkman L, . Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol 1994;47:363–74.
  • Roe CM, Mintun MA, D'Angelo G, Xiong C, Grant EA, Morris JC. Alzheimer disease and cognitive reserve: Variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol 2008;65: 1467–71.
  • Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448–60.
  • Gietema JA, Meinardi MT, Messerschmidt J, Gelevert T, Alt F, Uges DR, . Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer. Lancet 2000;355:1075–6.
  • Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, . Cisplatin-based therapy: A neurological and neuropsychological review. Psychooncology 2000;9:29–39.
  • Ajithkumar T, Parkinson C, Shamshad F, Murray P. Ifosfamide encephalopathy. Clin Oncol (R Coll Radiol) 2007;19:108–14.
  • Alici-Evcimen Y, Breitbart WS. Ifosfamide neuropsychiatric toxicity in patients with cancer. Psychooncology 2007;16: 956–60.
  • David KA, Picus J. Evaluating risk factors for the development of ifosfamide encephalopathy. Am J Clin Oncol 2005; 28:277–80.
  • Gerl A, Muhlbayer D, Hansmann G, Mraz W, Hiddemann W. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer 2001; 91:1297–303.
  • Thilers PP, Macdonald SW, Herlitz A. The association between endogenous free testosterone and cognitive performance: A population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology 2006;31:565–76.
  • Travison TG, Araujo AB, Beck TJ, Williams RE, Clark RV, Leder BZ, . Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometric measures of adult male proximal femur strength. J Clin Endocrinol Metab Epub 2008 Dec 23.
  • Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer 1996; 74:1674–9.
  • Green HJ, Pakenham KI, Gardiner R. Cognitive deficits associated with cancer: A model of subjective and objective outcome. Psychol Health Med 2005;10:145–60.
  • Ownsworth TL, McFarland K. Memory remediation in long-term acquired brain injury: Two approaches in diary training. Brain Inj 1999;13:605–26.
  • Smith PC, Kendall LM. Retranslation of expectations: An approach to the construction of unambiguous anchors for rating scales. J Appl Psychol 1963;47:149–55.
  • Cicerone KD, Dahlberg C, Kalmar K, Langenbahn DM, Malec JF, Bergquist TF, . Evidence-based cognitive rehabilitation: Recommendations for clinical practice. Arch Phys Med Rehabil 2000;81:1596–615.
  • Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, . Evidence-based cognitive rehabilitation: Updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005;86: 1681–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.